The iLite® cell lines are available for a number of biopharmaceutical targets and can be used for sensitive and specific measurement and quantification of drug potency, detection of neutralizing antibodies (NAbs) and assessment of immunogenicity.
The technology is based on a dual reporter gene assay and all cell lines are delivered as Assay Ready Cells, which means that they are ready to use, without any culturing or other pre-treatment.
An iLite Cell Based Assay is easy to run – similar to an ELISA where here, the cells act as the reagent and are ready‐to-use instantly after thawing. This format gives your assay a very quick turnaround time - all the iLite assays are performed within a workday or at most overnight.
Benefit from our off-the-shelf iLite® Assay Ready Cells or get a custom cell-based solution developed specifically for your drug development project.
Speak to one of our scientific experts and find out how our cell-based solutions can help you plan for your drug development initiatives in 2020.